檢索結果 - Sandip Pravin Patel
- Showing 1 - 20 results of 52
- Go to Next Page
-
1
-
2
-
3
-
4
Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations f... 由 Andrew B. Sharabi, Sangwoo Shawn Kim, Shumei Kato, P. Dominick Sanders, Sandip Pravin Patel, Parag Sanghvi, Elizabeth Weihe, Razelle Kurzrock
出版 2017Artigo -
5
-
6
-
7
Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma 由 Maria Schwaederlé, Sandip Pravin Patel, Hatim Husain, Megumi Ikeda, Richard B. Lanman, Kimberly C. Banks, AmirAli Talasaz, Lyudmila Bazhenova, Razelle Kurzrock
出版 2017Artigo -
8
-
9
-
10
-
11
ALKBH5 regulates anti–PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment 由 Na Li, Yuqi Kang, Lingling Wang, Sarah Huff, R. Tang, Hui Hui, Kriti Agrawal, Gwendolyn González, Yinsheng Wang, Sandip Pravin Patel, Tariq M. Rana
出版 2020Artigo -
12
-
13
Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy 由 Sadakatsu Ikeda, Aaron M. Goodman, Philip R. Cohen, Taylor J. Jensen, Christopher K. Ellison, Garrett M. Frampton, Vincent A. Miller, Sandip Pravin Patel, Razelle Kurzrock
出版 2016Artigo -
14
Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors 由 Ben Tran, Richard D. Carvajal, Aurélien Marabelle, Sandip Pravin Patel, Patricia LoRusso, Erik Rasmussen, Gloria Juan, Vijay Upreti, Courtney Beers, Gataree Ngarmchamnanrith, Patrick Schöffski
出版 2018Artigo -
15
-
16
-
17
A Complete Response to Combined Immunotherapy in a Patient with an ATM plus SF3B1 Mutation and a Moderate Tumor Mutational Burden with a High-Grade Treatment-Emergent Neuroendocrin... 由 Helena Ferreira Bruzzi Porto, Gabriela Carreiro Kubitschek Lopes, Hannah Barboza Vianna Bekierman, Sérgio Altino de Almeida, Felipe Andreiuolo, Evandro Lucena, Sandip Pravin Patel, Vinicius Freire, Daniel Herchenhorn
出版 2024Artigo -
18
Revisiting Epidermal Growth Factor Receptor (<i>EGFR</i>) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced Mal... 由 Shumei Kato, Ryosuke Okamura, Manvita Mareboina, Suzanna Lee, Aaron M. Goodman, Sandip Pravin Patel, Paul T. Fanta, Richard B. Schwab, Peter Vu, Victoria M. Raymond, Richard B. Lanman, Jason K. Sicklick, Scott M. Lippman, Razelle Kurzrock
出版 2019Artigo -
19
Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors 由 Sandip Pravin Patel, Teresa Alonso‐Gordoa, Susana Banerjee, Ding Wang, Jarushka Naidoo, Nathan Standifer, Doug Palmer, Lin‐Yang Cheng, Panagiotis Kourtesis, Maria Libera Ascierto, Mayukh Das, Jennifer R. Diamond, Matthew D. Hellmann, Benedito A. Carneiro
出版 2024Artigo -
20
Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers 由 Mingjia Li, Daniel Spakowicz, Jarred Burkart, Sandip Pravin Patel, Marium Husain, Kai He, Erin M. Bertino, Peter G. Shields, David P. Carbone, Claire F. Verschraegen, Carolyn J. Presley, Gregory A. Otterson, Kari Kendra, Dwight H. Owen
出版 2019Artigo
相關主題
Medicine
Internal medicine
Cancer
Oncology
Immunotherapy
Biology
Nivolumab
Cancer research
Genetics
Lung cancer
Clinical trial
Gastroenterology
Gene
Adverse effect
Immunology
Intensive care medicine
Immune system
Ipilimumab
Clinical endpoint
Receptor
Cancer immunotherapy
Disease
Liquid biopsy
Lung
Phases of clinical research
Biochemistry
Blockade
Breast cancer
Colorectal cancer
Computational biology